Our AI software is currently in the clinical development and investigation phase for obtaining Medical Device certifications. In compliance with current regulations (e.g., MDR), this product is intended exclusively for scientific research and pre-market evaluation purposes. The company declines all responsibility for improper use in violation of this notice.

Early detection starts here

Advanced AI-driven assistance to analyse dermatological images

🧬

AI-powered analysis

Identifies irregular patterns and anomalies.

🔎

Monitoring over time

Compares images and highlights subtle evolutions.

⚕️

Decision support

Helps dermatologists prioritise and evaluate faster.

In dermatological oncology, time is the variable that defines the prognosis. Identifying melanoma and skin neoplasms in their early stages exponentially increases survival rates, often turning a life-threatening condition into a treatable one. However, visual complexity makes screening a constant challenge. Our technology exists to bridge this gap: empowering clinicians with objective and instant analysis to reduce diagnostic uncertainty.

We are open to strategic partnerships with clinics, research centers, and software companies that share our vision. Whether you are interested in participating in clinical validation or exploring co-development opportunities.

We place our technological know-how at the service of enterprises requiring innovation: we offer consulting, design, and integration of ad-hoc AI models tailored to specific needs.







    Viale Luigi Majno 28, 20122 Milano (MI)

    P.IVA: 14454230963

    © DermIA 2025. All rights reserved.